CompoAtlas

Oméga 3 Triglycérides 18/12 (Gélatine)

Food supplement declared in France, decision dated 22 July 2026

Oméga 3 Triglycérides 18/12 (Gélatine) (NŪMYA) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vitamin E, Huile de poisson. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
NŪMYA
Food business operator placing the product on the market
Calimia jacky
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2 capsules avec 250 ml d'eau
Directions for use
Prendre 2 capsules par jour avec 250 ml d'eau.
Intended populations
Men and women aged 18 and over, People over 60
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Heart problems, Taking anticoagulants, Taking blood pressure medication, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Arteries and cholesterol, Nervous system, Eye / Vision

Declaration 367826, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Other active ingredients

NamePer day
Huile de poissonnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-alpha-tocopherolVitamin E300 mg30 mg

Additives

E422

Other ingredients

eau, Gélatine bovine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

La dose journalière recommandée ne doit pas être dépassée. Un complément alimentaire ne se substitue pas à une alimentation équilibrée et variée ni à un mode de vie sain. Tenir hors de portée des jeunes enfants. Contient du poisson et de la gélatine bovine (allergènes). Demander l'avis d'un professionnel de santé en cas de traitement anticoagulant, antihypertenseur, ou avant une intervention chirurgicale.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Huile de poisson
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : NŪMYA

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Oméga 3 Triglycérides 18/12 (Gélatine) (NŪMYA): composition and regulation”, https://compoatlas.com/en/supplements/products/367826-omega-3-triglycerides-18-12-gelatine, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line